Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03161301 · ClinicalTrials.gov registry record
Role of IL-37 Genetic Variants in Modulating Innate Immune Response to Periodontal Pathogens
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 86
- Enrollment target
NCT03161301 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 86 participants.
The verdict
NCT03161301 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This study will provide mechanistic insight into the underlying causes and molecular level pathogenesis of periodontal diseases. We will identify key mechanisms that confer risk and protection. Ultimately this will lead to new and improved diagnostics and therapeutics. Because periodontal disease is a uniquely accessible biofilm-associated disease it will provide insight into many other diseases such as inflammatory bowel disease and chronic infections associated with indwelling catheters and artificial prostheses. Subjects with periodontal conditions will have therapeutic benefit from the treatments provided.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2015-05-07 |
| Est. Completion | 2019-05-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03161301
The ClinicalTrials.gov registry entry for NCT03161301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03161301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03161301 about?
NCT03161301 is a clinical study titled "Role of IL-37 Genetic Variants in Modulating Innate Immune Response to Periodontal Pathogens". This study will provide mechanistic insight into the underlying causes and molecular level pathogenesis of periodontal diseases. We will identify key mechanisms that confer risk and protection. Ultimately this will lead to new and improved diagnostics and therapeutics. Because periodontal disease is...
What is the current status of trial NCT03161301?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2015-05-07. Estimated completion is 2019-05-24.
Who is sponsoring clinical trial NCT03161301?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.